N
Google TrendSOX SCORE (1000+) — MLB playoffs 2026: Inside White Sox's postseason pitching plan
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:sox score1000+bill maher500+ben simmons500+lisa200+sherrod brown1000+mn gophers2000+will venable1000+kalshi1000+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "FDA’s New Cell and Gene T" (30 stories)

Top Headline Story

Cell therapy weekly: FDA draft guidance to help accelerate cell and gene therapies
Lead StoryRegMedNetgeneral
Jun 4

Cell therapy weekly: FDA draft guidance to help accelerate cell and gene therapies

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPVjdkdTN0WGQ2eGNVaVE5MThaUVlhNnJsWWsxeDNCSmREWTlmWWltX0RCb1p3UnRIWXQyVmp5alozZFRFTXVfdm9BaTE2MlNTNml2SFhiYlRZMXY4MHhKdUtfYjMwaUR1eGktLTYyakFHYjFHZ0Z6NURJVEVYQllFOUdhd2hBWW1FVTN4d0dGUVhRWU8zT3RiQWdGWUNxcHA0OERwQWRYdmdUdVhF?oc=5" target="_blank">Cell therapy weekly: FDA draft guidance to help accelerate cell and gene therapies</a>  <font color="#6f6f6f">RegMedNet</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
1000+24m ago

sox score

MLB playoffs 2026: Inside White Sox's postseason pitching plan

Filter stories
500+24m ago

bill maher

Michael Douglas Tells Bill Maher About Smuggling Marijuana in Suitcases, Slams ‘Nepo Baby’ Label

Filter stories
500+24m ago

ben simmons

Ben Simmons to make his Kings debut against Golden State

Filter stories
200+24m ago

lisa

Trump Announces White House Inquiry Into Fed Governor Lisa Cook

Filter stories

Search Results for "FDA’s New Cell and Gene T"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
UPDATED: FDA illuminates new approval pathway for bespoke gene editing therapies
Fierce Biotechgeneral

UPDATED: FDA illuminates new approval pathway for bespoke gene editing therapies

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxONXcwdUxrY3Rvc2g1V01YUGNmQUpEMHVoVVE1RTZOVnBsSXFXTW1qeFlmYTdVR1ctMDhCU0JZN3RGcDVsMWhVWTNWTzdTQTd2S3hnam1ra3JiU3llMlBvMzNmVEEzY1pIQmRfamx4MU5NbmlzRm5HekpZMUY4THNxYTJpLUlkQWFiVW94elViT2l6SmhhTUpyQ3R1ZVlCQQ?oc=5" target="_blank">UPDATED: FDA illuminates new approval pathway for bespoke gene editing therapies</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
RiboX’s Circular RNA CAR-T IND Clearance Forces the Industry to Rethink Everything It Knows About Cell Therapy Trial Design
The Clinical Trial Vanguardgeneral

RiboX’s Circular RNA CAR-T IND Clearance Forces the Industry to Rethink Everything It Knows About Cell Therapy Trial Design

<a href="https://news.google.com/rss/articles/CBMilgJBVV95cUxPLTBTOXVJZjhlR3RCdHFCR19sdE1iZ0c5QjN0aFlTaWFyN2lxZXJaMHgzYkduVHh6VGlrN2xXNEM4OGVaR1VPWjBmZHgxZ3JsTVJqaThhbVJsdUJGbF9ta2ZQWVNZZ0plSGlqV0hQaVd6QmhXUGJOaWdlSXdmZXNSU2hFQlJVNnNILUZmTGNoR1dTVXRacDdnMnJmbllZck1KT2NjNzZjbWZuSlNqdnhxNW5WZ0dNUEx0bWxiZFZCbWQ3UEk1YlRqNXRSMmV0c21mQ1pXWUwtVktmXzNtYl9pRVZtaWVsc09PcXF6T19uZU03a1UtdkQ5N3FVWUdBRDJ5SmRRakVGdGRyVVRpeEZTdjJ4MVlmZw?oc=5" target="_blank">RiboX’s Circular RNA CAR-T IND Clearance Forces the Industry to Rethink Everything It Knows About Cell Therapy Trial Design</a>  <font color="#6f6f6f">The Clinical Trial Vanguard</font>

Read Full StoryMore like this
Why Industry Is Questioning FDA’s Data-Sharing Push in Cell and Gene Therapy
BioSpacegeneral

Why Industry Is Questioning FDA’s Data-Sharing Push in Cell and Gene Therapy

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOdEFmQjZncUJ0TUlzal9xejZzTXR4QjY2VDBXNWpST3IyZGo3WVJjeDJTUzFRcFFrcllORVJfWDliSG9OaEZ6R2xtMjBYTkdMT3hLQ2E1WER6c0dNLUw1UndhX0xEZlB1eFBDSnZHYVl2d1N1M0Y1ck93eFJBemRMX1NWWmdtS1NnWE5Nbjl2ekRJUjlSWXZmWVpOZXlHQm5nOGcxbkdSNA?oc=5" target="_blank">Why Industry Is Questioning FDA’s Data-Sharing Push in Cell and Gene Therapy</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
Around the Helix: Cell and Gene Therapy Company Updates – April 8, 2026
CGTLive®world

Around the Helix: Cell and Gene Therapy Company Updates – April 8, 2026

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxNZE9VZWpyT1FfbHJ3Yk40akd0dnlqeU9NZ2FVbkxuMXZ0Ty1ZMnk5dGE3cW95NXMwYW5sbDR5eDZJVnZsYkFjZHZmMFNTUnpVY0Z6YjJZN3FnblJ0LXVSZEN2ZVRfeDRRN2hYOGM2T3BCUERsVmVINnZFVExlcEF5aWdSVWhYLXNUS1ozUDVUdDJtd2ZBcEFSYUsyY0M?oc=5" target="_blank">Around the Helix: Cell and Gene Therapy Company Updates – April 8, 2026</a>  <font color="#6f6f6f">CGTLive®</font>

Read Full StoryMore like this
Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation
WashU Medicinegeneral

Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOM2NiNkJ5a1NBWTRvdE11UURBQ2tHa3EtaVMwdGZaaUFUckFKckZSem5oNGU0RXJDU2IzcHZQbld1a1R0SV9iOWFvd1AxVG00dWc5bXh0d05OZU5vTTdyekdvZ0Vaa01WTERUTm9GUFMyMmVRd2hzY1J1RzMtcTIwSEUya0RQckJ1bGhYTGhpRlMzSVhyVGp1bjluT0oybXlxUjhtSGVEMXJ3MEVU?oc=5" target="_blank">Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation</a>  <font color="#6f6f6f">WashU Medicine</font>

Read Full StoryMore like this
New CAR T-Cell Therapy Earns FDA Breakthrough Status in T-Cell Malignancies
CancerNetworkgeneral

New CAR T-Cell Therapy Earns FDA Breakthrough Status in T-Cell Malignancies

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQc2V5VEpybHZrNVFzVEdDRmRsaEI2NUt2emNyWGlRS3hIbnFwbE5HRmJqaW55M05KcTBHUm1yZUoxYkczcnU2VlozZmhxX1Itd01yVjViWmEyZkdKOEdfQXpRMlpJckRpNTVPdFpPeTd2UlowdU1yb1lsYXU0WGY3bE5SdFFDSkhWUzBGb2V6Xy04YkVRRjlsTTRNUV8zMDNzV09meTZnMXNJQjlPM3hn?oc=5" target="_blank">New CAR T-Cell Therapy Earns FDA Breakthrough Status in T-Cell Malignancies</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Rare disease advocates fume over FDA’s mixed signals
STATgeneral

Rare disease advocates fume over FDA’s mixed signals

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxPZU8yZlF0MWxWRHZiLUY1dW95THEyWHlVa1BjUlVnMHl5R2JGRElaSFQtdlJsdWxEX0NIZ1pZOU13bFFscHdlamdnZ0cwUWVjTVFxbk0tb3B1WDN1TFhrSURza0VUQXh0WGxLcTVjWDR4aGc4blc1WDRRcFZlVHpHT3VLXy0xLUdtUGhVM1NCY1M?oc=5" target="_blank">Rare disease advocates fume over FDA’s mixed signals</a>  <font color="#6f6f6f">STAT</font>

Read Full StoryMore like this
FDA removes barriers to cell, gene therapy development
pharmaphorumgeneral

FDA removes barriers to cell, gene therapy development

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxNLThIa3RDcUtHdU5LcU9FSUxKU3Zaa0Y2MkFHUlZyMkFIU0RUUWpHZFdzblpSNVoyQjVRVUVwYklxdDNQZDdwTVRBVjJkTFVhNVhiM3NIUGJLMlpVUmtmZ1p1ZVp2RFlJNktOZnY3U09xY0hBRy1lZDhwTGFVQkxWdUFGYUNWT2s?oc=5" target="_blank">FDA removes barriers to cell, gene therapy development</a>  <font color="#6f6f6f">pharmaphorum</font>

Read Full StoryMore like this
FDA pushes back Orca Bio cell therapy decision to July
FirstWord Pharmageneral

FDA pushes back Orca Bio cell therapy decision to July

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE84ak1nTlh5TzdXTWdEVDE1VmZTRDIzVHQ4N0pHajNWX0E0QXMzU3lzc3k0QmFwUldpWFdzYng3TmV6ei1lVlZpWHBibU5WTnVHWmF3?oc=5" target="_blank">FDA pushes back Orca Bio cell therapy decision to July</a>  <font color="#6f6f6f">FirstWord Pharma</font>

Read Full StoryMore like this
F.D.A. Faces Upset Over Denials of New Drugs
The New York Timesgeneral

F.D.A. Faces Upset Over Denials of New Drugs

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxPOFgydVZ4ZDAtYUJjaG94Z0JwVzdxOFVyVnFsOVBLWEtXY1puaGNUS1ZFRUdobU5LUTJCY3BEc0Itc0RLVnpSc0w0Zjh2MW80c1p1dndzNF82WEtRRmF4YzJsYVdyNm9sem5HVThEVWlHdFRGSFh2VDlKTUQxWVBvaUlWOA?oc=5" target="_blank">F.D.A. Faces Upset Over Denials of New Drugs</a>  <font color="#6f6f6f">The New York Times</font>

Read Full StoryMore like this
This Week’s CGT News: New FDA Genome Editing Guidance
The Medicine Makergeneral

This Week’s CGT News: New FDA Genome Editing Guidance

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQRURNYjRTcl8tb3hXWUN3Qy02cF9sU0NacDBkLVdwaDN6am5LWjNZQlo2TEJMSmVNdUFTeTU1eWdfcWFOV1VUZzdBTHhDdy10enlCbjJhdV9YeTdlVEZxMjJxOElvUGhuTFlzWHBCdHFNRnBWZEZ6bTVWTVVqajVuczlBTnN0R21WenB5SlFqX1lHS0FFenlwQzY3ZHVVdElSSDR3U0dFampqZFRW?oc=5" target="_blank">This Week’s CGT News: New FDA Genome Editing Guidance</a>  <font color="#6f6f6f">The Medicine Maker</font>

Read Full StoryMore like this
FDA extends review of Orca Bio’s novel cell therapy for blood cancers
Fierce Pharmageneral

FDA extends review of Orca Bio’s novel cell therapy for blood cancers

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQeEpLeGZFSEdaWE9INEc2WWlTa3VFUW1JUnd5Q3loY2pIeW1ROTdEZzA3cHVXM3BjMUhVdC1MN1FjTmJDaVI5SWx5LUI5SUM4d3FIQWJOZW1ldmtMc2dXLVEtbTVPaGY3bU9nM1hKTl9SOFlFWE1wSFRuWjd5ZkJ1QkNRb05YM3ZPX3NwOUJWMS05MGpnZWJvNXZPOVFRUU5Zb0tQUXM4MA?oc=5" target="_blank">FDA extends review of Orca Bio’s novel cell therapy for blood cancers</a>  <font color="#6f6f6f">Fierce Pharma</font>

Read Full StoryMore like this
Potentially “groundbreaking” FDA gene therapy pathway leaves key issues unresolved
Clinical Trials Arenaworld

Potentially “groundbreaking” FDA gene therapy pathway leaves key issues unresolved

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNa3Z6eTFkbTJNUFpSeC1NaFJzcG9LVG5KMTBjTkJtVl9IRXBsWWlJT2JjWWdtZWh1QTUxbXNhc0dfazdFRzloZmRZWlVOMGpWcm5WSXVjNmZudVZlVEJDNzY5ZTNoLTM2ZUJCZEozQmxOdVFpRGdGN3dEN0RXaFVjOFpQT0h5cmFUWjlDNkNYRUJGMFhMMU0xUUpnVllPakdDcldJZ2szNHZ6NGFXUkYyMmN2bzVsaVBNbkI3WHJxZi1qZFo0dlhz?oc=5" target="_blank">Potentially “groundbreaking” FDA gene therapy pathway leaves key issues unresolved</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
FDA Decisions to Look For in 1H 2026
CGTLive®general

FDA Decisions to Look For in 1H 2026

<a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTFBhMEpfQ3JaTWpmazh0ZXRRNVpWenB6TWJTUmxac2M4Z3lhY1hZd203em5DbmlmeEZ6Tkl0eFZ2SEtqaS12NVpkVXlYZE5ldC0xRF8wVlJjMVlyT2h2aUVJN2ZqSXhBQQ?oc=5" target="_blank">FDA Decisions to Look For in 1H 2026</a>  <font color="#6f6f6f">CGTLive®</font>

Read Full StoryMore like this
Lawmakers urge FDA to enact new China policies after 3 gene therapy trial deaths
BioSpaceworld

Lawmakers urge FDA to enact new China policies after 3 gene therapy trial deaths

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQdl9rZnFWamxQY3Y1b1FjbGRzS2dFdE1BaFFOaVhlcTRQNFJGMmFWQnVPNG9tQXUwSjJhNDlkVGhRdkc2cnNLSXBZcWd1MHVWdDBNdzNReXA0UHF1SFhTZFdfdVQyRkwwWmhrdks0S0xVNFU5dUVXSmRBMGFoVURpS2Jkbm12aWdmc3lIVmdLNER5Nzl6dFB3ZVMxcHdaM3g5blpsZmtvcjNqQQ?oc=5" target="_blank">Lawmakers urge FDA to enact new China policies after 3 gene therapy trial deaths</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
FDA official confirms plausible mechanism principles not exclusive to bespoke gene therapies
Fierce Biotechgeneral

FDA official confirms plausible mechanism principles not exclusive to bespoke gene therapies

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNdWR4NnB5bVZuZlJSWjZhYVY3LTNnZ1E3ekI3b0llQldDY1ItXzZveDdoWV9icDFaNlEtMWJ0WTNwM3FidWNfUzdVd24xanRxSk9WQlZ6UTBUZjVoOVVGQXlTYm5oNC1uU21WaUpjWHlzbVBsZi05US1XWU1BV3JIX3h2M2ZpZHhQdTUwNFJOXzZoUkZEN0h1TDNIMEJaa2xmNnZCeG1MRlV2MHlqRk96MWtLRE81QnNIQXc?oc=5" target="_blank">FDA official confirms plausible mechanism principles not exclusive to bespoke gene therapies</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
FDA signals tailored approach to ‘carefully shepherd’ CAR-T therapy for autoimmune diseases
Fierce Biotechtech

FDA signals tailored approach to ‘carefully shepherd’ CAR-T therapy for autoimmune diseases

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxOTm1heXRLS0JSQ2pEaXVoYUJUVHJWNDNOSnBnYzdGOFFSNHVmYU43SVI2OFdVLVFuU01CdkJkQ2pJMkNhWkh3ZkxYTDVacHdTd3BPc3h3RV9nWUh1ZEJHUWFNY3g1cTNVaXQ4X2ZDdEdVb240LUdVTG4yZnByeklmVWVPT1V4LWRUdUxuYUwwZFNINThzS2VNdkRXZ2loWllhUUR4UGY5ei1jLUxweVNJWGM2bFFnWHU0ZXJJcg?oc=5" target="_blank">FDA signals tailored approach to ‘carefully shepherd’ CAR-T therapy for autoimmune diseases</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
FDA steers cancer CAR-T developers toward randomized superiority trials in policy shift
Fierce Biotechgeneral

FDA steers cancer CAR-T developers toward randomized superiority trials in policy shift

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxNUWdRVFpkM2NJQlVnMzl5eU16UUZuNmFUQ2hvTDFyVDFBUlFPdm8yVEFrNnRsNlFHRHQyOHM3TTEtLU1qZnN2Qkl3VFFnMkdNamZnaTI4QXlwUGtjaU9Zc3ZjbEJVc3pEZUw0OERyM2hKRmROd2luRzVLOGw2bWZUM1pkWTJ2dTZLLWZldHVyUkNjYUJUTElkVGJUUXZxUk91V3liMThlR3FDMVFvampjWTJhSDNLc2JscjQwY3Y4NA?oc=5" target="_blank">FDA steers cancer CAR-T developers toward randomized superiority trials in policy shift</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
UPDATED: Prasad, Makary unveil new FDA path for accelerating custom gene editing therapies
Fierce Biotechworld

UPDATED: Prasad, Makary unveil new FDA path for accelerating custom gene editing therapies

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPMWJkVmZ2QmVEcnczMV9fZmxtWlVZdWhKYjlLTHdsX0t1SUttMHJYcWZ0SkhDN2lKX0hITTFUcFpyYzdhS2xIX0lTc2ppb1VHLXFPeW0yZ19XWHFKdHhYSHA4LVU1MGVTM3V4OWdpY1VaV0lfZVFTaTcxY1lmTGFSMkpWMkZORFktNmxxZlF3c2FqOTBoSmp0TmUyU0tQMno4bDFXdTdXdDJCYURpSzNyLVlmRnpLdnc?oc=5" target="_blank">UPDATED: Prasad, Makary unveil new FDA path for accelerating custom gene editing therapies</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
FDA’s acting director of cell and gene therapies to leave position
Endpoints Newsgeneral

FDA’s acting director of cell and gene therapies to leave position

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPWWZWTDZxMWVZQTdoSzZqaS1pd3hMOTF6WjVmcE5xVkJFN2tHSHBvVkRNWlNIN2JtS2hldjg0SnZudWowVGRTVFhaQ1dVMHpIeG1pT2V1emNVbWlGVl9QSmQwMFNIRUY3YUFDczhpcW9pcU5iTDZuVThxbWFnZThBcnhwNW8xaVVhaEV5dkpkaDBuNkk?oc=5" target="_blank">FDA’s acting director of cell and gene therapies to leave position</a>  <font color="#6f6f6f">Endpoints News</font>

Read Full StoryMore like this
Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook
Fierce Pharmaworld

Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNSkVPU1R6SHRwWW15SngxcXptN1BNLVdKMk5vUUhVbFc3TWpuNzEyNDJoRWszelh3bGF6YmxGWHdSbE53WjBwMDd1aWQxUmpqdVpEczM3YUFpcklTSFVTdi1iaFdHdV9UWFRWVGFieVV5OHcxUi1TYkJLZDVPbHhaaDNVLWlMTHVHd2gzZzEyYmJtUWNjRmVV?oc=5" target="_blank">Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook</a>  <font color="#6f6f6f">Fierce Pharma</font>

Read Full StoryMore like this
FDA’s latest CGT guidance streamlines path for in vivo CAR-T development
Clinical Trials Arenageneral

FDA’s latest CGT guidance streamlines path for in vivo CAR-T development

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNMzVGdk85Y194eng5c1EwY3p1eV9tZXp1UGI0Vzc2MzlzZHBvRmZsVVNKcU9uYmVfQXVoeHZmR28tTWVCS3d0eEZXSHA4eGRpUkN4WDAtUExXU290LU9IQjdKX05aUWN0cHlpNFBseWtMSUN0am5LRm01ZjdwZE1xdlc4MWNQWTUwQ20yTmRHTHBsbFpQYkFKTHJQcXlWR1BBM2NYeWxxVElVc3F4azgtMFBOZGN1RWZtTm9R?oc=5" target="_blank">FDA’s latest CGT guidance streamlines path for in vivo CAR-T development</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
FDA Hits Atara Biotherapeutics’ T-Cell Immunotherapy Tabelecleucel for EBV+ PTLD With Second CRL
CGTLive®world

FDA Hits Atara Biotherapeutics’ T-Cell Immunotherapy Tabelecleucel for EBV+ PTLD With Second CRL

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNamZnTTlWdWdEa25uR2h0MUhsU3FPTEJkc3cwVGFPWWh2XzRrZHJ0M2hNVmN5MUE4MUdQRThxcG9NQ0QxS2JuYmp6di1SRlRIMG1UZVlCQ1pxNWtMXzQyaWt3LUk5MUtaNjdGbl82QzE1MlFCZzh0bl9RNGJ5M3JWMzBxdVNBSV9SWnhlUnhsa0hnLVRjdi1LQzVOWDBIOVVuV19kckFVWHNuQlJMOFoxZG5GN2c?oc=5" target="_blank">FDA Hits Atara Biotherapeutics’ T-Cell Immunotherapy Tabelecleucel for EBV+ PTLD With Second CRL</a>  <font color="#6f6f6f">CGTLive®</font>

Read Full StoryMore like this
Opinion: How the FDA Is Accelerating Cell and Gene Therapy’s Next Chapter
BioSpacegeneral

Opinion: How the FDA Is Accelerating Cell and Gene Therapy’s Next Chapter

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQc1ctODNPZlhLQVJmLTRmYUs3NGU0RDkzLWtRa1l0OURINllHdjFXclUzMy1kbWFCX0tVU3llRTA3TEpLelk4ZWZWbXV5MVMwTUJSTS0yZWdLcm11SERWeWVnR2RmX2tIWVdVaTN4QWxHZklWYnlNYnpNOEtqeG9oWXp5eEpnb1Z5bGNlZUI0UXFIVHY1RmEwaTQ5Q1Ayd19ja3c?oc=5" target="_blank">Opinion: How the FDA Is Accelerating Cell and Gene Therapy’s Next Chapter</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
How a 'healthy exchange of ideas' with RFK Jr. kick-started FDA's gene therapy push
Fierce Biotechscience

How a 'healthy exchange of ideas' with RFK Jr. kick-started FDA's gene therapy push

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQeTdKMThCVUZta3F1aUJvc3JjanRPZEtuZlJ4c1hGZ1JmYzhZQ2lsX0Q2REloSTdSZEdsM19IUEtGbnNnYVpsdDMydkFoM3pNOGdZaWttOGsyVDlNd05NTTJXcnF6Z0pJbVlHWmlMd19yb2N6NENvdkp3Y29oZjNlMnJibkRzaTBGajM4OS1qcUE5TVZYSkJLcEozM2VHX2I0dzg0?oc=5" target="_blank">How a 'healthy exchange of ideas' with RFK Jr. kick-started FDA's gene therapy push</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
Kelonia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KLN-1010, an in vivo BCMA CAR-T Therapy for Relapsed and Refractory Multiple Myeloma
Business Wireworld

Kelonia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KLN-1010, an in vivo BCMA CAR-T Therapy for Relapsed and Refractory Multiple Myeloma

<a href="https://news.google.com/rss/articles/CBMi0wJBVV95cUxOeU1iQkVrV3BfclNNV053M21zSkhuRlI1VzVWdTBWeGg3Qnc0S3V1LTJxMS1wSE5SbHdUMG1xaW56d1ZLNVBTZjBaU3ZkTkQ3YU16UGhrVHA1clJydjAxUnFTR0dBX1ZiT0FzMEFyeHdGTWpfajY5Y3BhYnFoN3FNVmdrclc3X0dZal9rZ0ZQOE1YTERHQmN6NTQxWGRCRHRFYXoxdENlc0x1ZFF3Y3VZaTdZTjkwN1RJeGVENzRlRUdrNzVHUVI1eDZpUnFIOXQycm5wcl9FMC1IOG9RWU5nZ2JIWFNuQVh2SWw3ZkoyQW1DbXRqdmhPV1RrQW5nVW1ycUNDRmVLNGF3cEV6MkprZFk5bXVrYTNXdzNEZmxiOXFVVHNlWXQzdXRER1MtblQ0Unpocjd0OGVYNUFCTjAteUNWX0FsYXBXYmUxbkM4LS0zSFU?oc=5" target="_blank">Kelonia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KLN-1010, an in vivo BCMA CAR-T Therapy for Relapsed and Refractory Multiple Myeloma</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
FDA cell and gene therapy guidance informs pharma strategies
Drug Discovery & Developmentgeneral

FDA cell and gene therapy guidance informs pharma strategies

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxOaG5zOEdpNXd5STc5TVltSVdKazhtNXBaeGRIVmV3bTJ4LXNZdmZpdEJaVnlBbzRhcUFLQlY1TXhCSGRWdUhkQnVFT3dGaVNpamlWVF9ucFRHQjUyaG8xNGNVV2wyY2pDaXNKMTFzdzdkWlZwSnIwbU5wUTRtNUk1X3laY045SzU5Z09qQmdVME9keWxLTUxLM0hNU21EZldUcjctWXpnS0x0TFNoZ0hGclpNY004SWl2WDR2UnBOWndqQjNqcVFLVQ?oc=5" target="_blank">FDA cell and gene therapy guidance informs pharma strategies</a>  <font color="#6f6f6f">Drug Discovery & Development</font>

Read Full StoryMore like this
Why gene and cell therapies are stalling at the FDA
Drug Discovery Newsgeneral

Why gene and cell therapies are stalling at the FDA

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNVjF2blV4algzUGtlTVgzRzBnUmdoLTBXcEtjQmVzSGppSWZyUXlQLUl5MXdKaF9uNDJUTi00cC14eUowMmRMd3kxMHVHZlNoN2R5VTI5ZEdlSE9PV2hqZDk5UnVrbkFReWZVNl9CbW5SY05IejJHUXhfX1lLZ1lhZGItNEExX2NpNzJjajk3Zzdxc1RlYWc?oc=5" target="_blank">Why gene and cell therapies are stalling at the FDA</a>  <font color="#6f6f6f">Drug Discovery News</font>

Read Full StoryMore like this
FDA’s New Cell and Gene Therapy Guidances Finally Go a 'Click Further' to 'Game Changing'
BioSpacegeneral

FDA’s New Cell and Gene Therapy Guidances Finally Go a 'Click Further' to 'Game Changing'

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxQeVh2VENsaXZiRTRPM3VYYXpFV3d3Skt5eGo5QVJqUUJ5c2tFVTNDWnBqeDViOTVBU3Yxb3JqRFpLeWJybjlVN2JLZi1vWXI3NHlicmd2cW9EOWttWnpvLTNPTFp3eW1rbU83OGJBNzJWOGRmTmRPbUVpNWo4UENidWN2c0NkQ1g1MmZmdFJOU05LNVFDRURpNmlzNk93RVBncktsRkhoWnFKb2hyOV85bzBzTQ?oc=5" target="_blank">FDA’s New Cell and Gene Therapy Guidances Finally Go a 'Click Further' to 'Game Changing'</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
"FDA’s New Cell and Gene T" — Live Google News Trends & Headlines